tiprankstipranks
Boston Scientific (DE:BSX)
XETRA:BSX
Germany Market
BSX
Boston Scientific
RESEARCH TOOLSreports

Boston Scientific (BSX) Ratios

12 Followers

Boston Scientific Ratios

DE:BSX's free cash flow for Q2 2026 was $0.71. For the 2026 fiscal year, DE:BSX's free cash flow was decreased by $ and operating cash flow was $0.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.24 1.62 1.08 1.32 1.51
Quick Ratio
 0.74 1.08 0.64 0.82 1.02
Cash Ratio
 0.08 0.38 0.06 0.18 0.24
Solvency Ratio
 0.25 0.22 0.18 0.18 0.12
Operating Cash Flow Ratio
 0.70 0.83 0.54 0.51 0.40
Short-Term Operating Cash Flow Coverage
 2.65 11.66 1.93 4.71 76.30
Net Current Asset Value
$ -12.07B$ -10.41B$ -10.47B$ -9.09B$ -9.14B
Leverage Ratios
Debt-to-Assets Ratio
 0.28 0.28 0.28 0.27 0.29
Debt-to-Equity Ratio
 0.51 0.51 0.51 0.49 0.53
Debt-to-Capital Ratio
 0.34 0.34 0.34 0.33 0.35
Long-Term Debt-to-Capital Ratio
 0.30 0.32 0.29 0.31 0.34
Financial Leverage Ratio
 1.81 1.80 1.81 1.82 1.85
Debt Service Coverage Ratio
 2.65 6.25 1.62 3.81 4.75
Interest Coverage Ratio
 12.41 11.38 6.81 8.02 3.93
Debt to Market Cap
 0.20 0.08 0.08 0.11 0.13
Interest Debt Per Share
 8.79 8.62 7.84 6.72 6.81
Net Debt to EBITDA
 2.13 2.03 2.73 2.50 3.05
Profitability Margins
Gross Profit Margin
71.16%69.01%61.31%62.02%60.83%
EBIT Margin
20.91%18.60%15.94%15.85%12.66%
EBITDA Margin
27.06%25.42%23.51%24.25%21.61%
Operating Profit Margin
21.46%19.78%15.73%15.32%14.38%
Pretax Profit Margin
18.39%16.86%13.63%13.94%9.00%
Net Profit Margin
17.47%14.38%11.07%11.19%5.50%
Continuous Operations Profit Margin
17.47%14.41%11.02%11.18%5.50%
Net Income Per EBT
94.98%85.26%81.24%80.25%61.17%
EBT Per EBIT
85.69%85.24%86.60%91.01%62.55%
Return on Assets (ROA)
8.11%6.61%4.71%4.53%2.15%
Return on Equity (ROE)
14.90%11.91%8.52%8.26%3.97%
Return on Capital Employed (ROCE)
11.62%10.39%7.99%7.22%6.36%
Return on Invested Capital (ROIC)
10.57%8.78%6.13%5.69%3.89%
Return on Tangible Assets
18.65%15.71%11.87%10.80%5.11%
Earnings Yield
5.76%2.04%1.41%1.90%1.05%
Efficiency Ratios
Receivables Turnover
 6.89 6.86 6.55 6.39 6.44
Payables Turnover
 4.92 5.44 6.75 5.74 5.76
Inventory Turnover
 1.87 2.11 2.31 2.18 2.66
Fixed Asset Turnover
 5.09 4.46 4.47 4.32 4.48
Asset Turnover
 0.46 0.46 0.43 0.41 0.39
Working Capital Turnover Ratio
 7.42 10.36 15.93 8.05 6.34
Cash Conversion Cycle
 173.81 158.81 159.96 161.16 130.54
Days of Sales Outstanding
 53.00 53.20 55.75 57.11 56.70
Days of Inventory Outstanding
 195.01 172.73 158.28 167.62 137.17
Days of Payables Outstanding
 74.21 67.12 54.07 63.57 63.33
Operating Cycle
 248.01 225.93 214.03 224.73 193.87
Cash Flow Ratios
Operating Cash Flow Per Share
 3.07 3.06 2.33 1.72 1.07
Free Cash Flow Per Share
 2.45 2.47 1.80 1.17 0.64
CapEx Per Share
 0.61 0.59 0.54 0.55 0.43
Free Cash Flow to Operating Cash Flow
 0.80 0.81 0.77 0.68 0.60
Dividend Paid and CapEx Coverage Ratio
 5.01 5.18 4.35 3.02 2.29
Capital Expenditure Coverage Ratio
 5.01 5.18 4.35 3.13 2.49
Operating Cash Flow Coverage Ratio
 0.36 0.37 0.31 0.26 0.16
Operating Cash Flow to Sales Ratio
 0.22 0.23 0.21 0.18 0.12
Free Cash Flow Yield
5.66%2.59%2.01%2.03%1.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 17.38 48.65 70.89 52.73 94.83
Price-to-Sales (P/S) Ratio
 3.05 7.03 7.85 5.90 5.22
Price-to-Book (P/B) Ratio
 2.55 5.82 6.04 4.36 3.77
Price-to-Free Cash Flow (P/FCF) Ratio
 17.67 38.59 49.69 49.32 72.42
Price-to-Operating Cash Flow Ratio
 14.06 31.13 38.26 33.56 43.37
Price-to-Earnings Growth (PEG) Ratio
 0.38 0.88 4.27 0.37 -2.69
Price-to-Fair Value
 2.55 5.82 6.04 4.36 3.77
Enterprise Value Multiple
 13.40 29.70 36.10 26.82 27.20
Enterprise Value
 76.15B 151.53B 142.17B 92.62B 74.54B
EV to EBITDA
 13.40 29.70 36.10 26.82 27.20
EV to Sales
 3.63 7.55 8.49 6.50 5.88
EV to Free Cash Flow
 21.01 41.42 53.75 54.39 81.56
EV to Operating Cash Flow
 16.81 33.42 41.39 37.01 48.85
Tangible Book Value Per Share
 -0.26 -0.56 -1.20 -0.59 -0.87
Shareholders’ Equity Per Share
 16.87 16.37 14.79 13.27 12.29
Tax and Other Ratios
Effective Tax Rate
 0.05 0.15 0.19 0.20 0.39
Revenue Per Share
 14.21 13.56 11.38 9.80 8.87
Net Income Per Share
 2.48 1.95 1.26 1.10 0.49
Tax Burden
 0.95 0.85 0.81 0.80 0.61
Interest Burden
 0.88 0.91 0.86 0.88 0.71
Research & Development to Revenue
 0.10 0.10 0.10 0.10 0.10
SG&A to Revenue
 0.34 0.34 0.36 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 0.01 0.02 0.02 0.02
Income Quality
 1.23 1.57 1.86 1.57 2.19
Currency in USD